Literature DB >> 18824911

Digoxin-specific Fab fragments as single first-line therapy in digitalis poisoning.

Frédéric Lapostolle1, Stephen W Borron, Carine Verdier, Pierre Taboulet, Gilles Guerrier, Frédéric Adnet, Jean-Luc Clemessy, Chantal Bismuth, Frédéric J Baud.   

Abstract

OBJECTIVE: Despite administration of Fab fragments in digitalis poisoning, high mortality rates are consistently reported. A previous study suggested that Fab fragments prescribed as first-line therapy might improve mortality rate. Our objective was to evaluate this approach.
DESIGN: Retrospective chart review (January 1990 to January 2004).
SETTING: University hospital intensive care unit. PATIENTS: Consecutive patients admitted for cardiac glycoside poisoning. INTERVENTION: First-line therapy with Fab fragments (with or without atropine) in either curative or prophylactic doses.
MEASUREMENTS AND MAIN RESULTS: A total of 141 patients were admitted for digitalis poisoning of whom 66 received first-line Fab fragment therapy. Their median age was 74 years (25th to 75th percentiles: 51-83); 76% were women. Half were intoxicated by digitoxin and half by digoxin. Median serum concentration was 168 (108-205) ng/mL for digitoxin and 6.2 (4.3-13.5) ng/mL for digoxin. Conduction disturbances were reported in 45 cases (68%) and ventricular arrhythmia in six cases (9%). Fab fragments were administered as curative treatment in 21 patients (32%) and prophylactically in 45 patients (68%). The median cumulative dose was 4 (4-6) vials. No adverse effects were reported. Five patients (7.6%) died.
CONCLUSIONS: First-line therapy with Fab fragments in patients with digitalis poisoning was associated with a low mortality rate.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18824911     DOI: 10.1097/CCM.0b013e31818b341c

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  9 in total

Review 1.  Pharmacological treatment of cardiac glycoside poisoning.

Authors:  Darren M Roberts; Gamini Gallapatthy; Asunga Dunuwille; Betty S Chan
Journal:  Br J Clin Pharmacol       Date:  2015-12-15       Impact factor: 4.335

2.  A comparison of simulation-based education versus lecture-based instruction for toxicology training in emergency medicine residents.

Authors:  Joseph K Maddry; Shawn M Varney; Daniel Sessions; Kennon Heard; Robert E Thaxton; Victoria J Ganem; Lee A Zarzabal; Vikhyat S Bebarta
Journal:  J Med Toxicol       Date:  2014-12

3.  Assessment of digoxin antibody use in patients with elevated serum digoxin following chronic or acute exposure.

Authors:  Frédéric Lapostolle; Stephen W Borron; Carine Verdier; Fabrice Arnaud; James Couvreur; Bruno Mégarbane; Frédéric Baud; Frédéric Adnet
Journal:  Intensive Care Med       Date:  2008-04-04       Impact factor: 17.440

4.  Anti-digoxin Fab variants generated by phage display.

Authors:  Viviane Midori Murata; Mariana Costa Braga Schmidt; Jorge Kalil; Lilian Rumi Tsuruta; Ana Maria Moro
Journal:  Mol Biotechnol       Date:  2013-06       Impact factor: 2.695

Review 5.  Drugs and pharmaceuticals: management of intoxication and antidotes.

Authors:  Silas W Smith
Journal:  EXS       Date:  2010

6.  Digoxin-specific antibody fragments for the treatment of suspected Nerium oleander toxicosis in a cat.

Authors:  Aaron F Galton; Marcella C Granfone; Dana J Caldwell
Journal:  JFMS Open Rep       Date:  2020-12-02

7.  Predictive Factors for Recurrence of Serious Arrhythmias in Patients with Acute Digoxin Poisoning.

Authors:  Ghada N El-Sarnagawy; Sara I El Sharkawy; Nadia E Helal
Journal:  Cardiovasc Toxicol       Date:  2021-07-14       Impact factor: 3.231

Review 8.  [Cardiac arrest under special circumstances].

Authors:  Carsten Lott; Anatolij Truhlář; Anette Alfonzo; Alessandro Barelli; Violeta González-Salvado; Jochen Hinkelbein; Jerry P Nolan; Peter Paal; Gavin D Perkins; Karl-Christian Thies; Joyce Yeung; David A Zideman; Jasmeet Soar
Journal:  Notf Rett Med       Date:  2021-06-10       Impact factor: 0.826

Review 9.  Pharmacologic Approach to Sinoatrial Node Dysfunction.

Authors:  Pietro Mesirca; Vadim V Fedorov; Thomas J Hund; Angelo G Torrente; Isabelle Bidaud; Peter J Mohler; Matteo E Mangoni
Journal:  Annu Rev Pharmacol Toxicol       Date:  2020-10-05       Impact factor: 13.820

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.